Welcome to our dedicated page for Sabra Health Care Reit SEC filings (Ticker: SBRA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Sabra Health Care REIT, Inc. (SBRA) SEC filings page on Stock Titan brings together the company’s regulatory disclosures as a Maryland-incorporated, self-administered, self-managed healthcare REIT listed on The Nasdaq Stock Market LLC. Through these filings, investors can review how Sabra reports its financial results, portfolio activity, capital structure decisions and other material events related to its healthcare real estate business in the United States and Canada.
Sabra’s Form 8-K filings frequently cover quarterly earnings releases, where the company presents net income alongside non-GAAP measures such as funds from operations (FFO), Normalized FFO, Adjusted FFO (AFFO), Normalized AFFO, net operating income (NOI), Cash NOI and Net Debt to Adjusted EBITDA. These filings often reference supplemental information packages and reconciliations of non-GAAP financial measures that explain how the metrics relate to GAAP results and how they reflect performance across skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities and specialty hospitals and other properties.
Other 8-K filings document capital markets transactions and financing activities, including equity distribution agreements supporting at-the-market equity offering programs, forward sale agreements for common stock, new term loans and the redemption of outstanding senior notes. These disclosures outline how Sabra raises capital, refinances debt and funds investments in its healthcare real estate portfolio.
On this page, Stock Titan provides real-time access to Sabra’s filings as they appear on EDGAR, along with AI-powered summaries that help explain key points from lengthy documents such as earnings-related 8-Ks and accompanying exhibits. Users can quickly locate quarterly and annual reports, review material definitive agreements, track changes in capital structure and understand the regulatory context around Sabra’s operations as a healthcare-focused REIT.
Sabra Health Care REIT, Inc. director Jeffrey A. Malehorn reported an automatic acquisition of 781 common stock units on February 27, 2026. These units were credited as dividend-equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and carried no purchase price.
After this transaction, Malehorn directly holds 107,219 common stock units, including 2,854 unvested units and 51,345 units that have vested but with payment deferred. Each stock unit represents the right to receive one share of Sabra’s common stock, following the original grant’s vesting and payment terms.
Sabra Health Care REIT, Inc. director Ann Kono reported an acquisition of 781 shares of common stock on a Form 4. These were stock units credited as dividend-equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan, at a price of $0 per unit.
After this grant, she holds a total of 59,059 stock units, including 2,854 unvested units and 51,345 units that have vested but whose payment has been deferred. Each stock unit represents the right to receive one share of Sabra’s common stock.
Sabra Health Care REIT, Inc. director Lynne S. Katzmann acquired 781 common stock units on February 27, 2026 as a grant credited in the form of dividend-equivalent payments under the company’s 2009 Performance Incentive Plan. The units were calculated using the market value of Sabra’s common stock on the dividend payment date and were issued at a price of $0.00 per unit.
After this award, Katzmann directly holds a total of 76,994 stock units. This total includes 2,854 unvested stock units and 51,345 stock units that have already vested but for which payment has been deferred. Each stock unit represents the right to receive one share of Sabra’s common stock, and the new units will vest and become payable on the same terms as the original stock units they track.
Sabra Health Care REIT director Michael J. Foster reported an acquisition of stock units tied to common stock. On February 27, 2026, he was credited with 781 stock units as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan, at a stated price of $0.00 per unit.
These new units will vest and become payable on the same schedule as the original stock units they track. After this credit, Foster directly holds 74,719 shares of common stock, which include 2,854 unvested stock units and 51,345 vested stock units with deferred payment, each representing the right to receive one share. He also indirectly holds 42,411.745 shares through a 401(k) plan.
Catherine Cusack, a director of Sabra Health Care REIT, Inc., reported an acquisition of 781 shares of common stock on the basis of dividend equivalent payments on previously granted stock units. The award was priced at $0.00 per share, reflecting a stock unit credit rather than a cash purchase.
After this transaction, Cusack’s direct holdings increased to 72,929 stock units and shares, including 2,854 unvested stock units and 51,345 vested stock units with deferred payment. Each stock unit represents the right to receive one share of Sabra’s common stock under the company’s 2009 Performance Incentive Plan.
Sabra Health Care REIT, Inc. reported that director Craig A. Barbarosh acquired 781 common stock units on February 27, 2026 as a grant/award. These units were credited as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan at the market value on the dividend date.
After this award, Barbarosh directly holds 54,199 common stock units, including 2,854 unvested units and 51,345 vested units whose payment has been deferred. Each unit represents the right to receive one share of common stock. He also indirectly holds 94,916 shares through The Barbarosh Family Trust.
Sabra Health Care REIT, Inc. Executive VP & CAO Jessica Flores reported an acquisition of 368 shares of common stock on February 27, 2026. The transaction was coded as a grant or award, with a price of $0.00 per share, reflecting stock units rather than a market purchase.
According to the footnotes, these units were credited as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and will vest and pay out on the same schedule as the original awards. After this award, Flores directly holds a total of 86,940 shares/units, including 25,527 stock units that will settle on a one-for-one basis in common shares.
Sabra Health Care REIT, Inc. reported that Executive VP, CIO & Secretary Darrin Smith acquired 478 common stock units on February 27, 2026 as a grant/award. These units were credited as dividend-equivalent stock units based on the market value on the dividend payment date and carry no cash purchase price.
After this award, Smith directly holds 115,923 common shares/units, including 33,186 stock units that will settle one-for-one in Sabra common stock. The new dividend-equivalent units will vest and become payable on the same schedule as the original stock units they track.
Sabra Health Care REIT, Inc. Executive VP, CFO & Treasurer Michael Lourenco reported an acquisition of 4,005 shares of common stock on February 27, 2026. These reflect stock units credited as dividend equivalent payments on previously granted stock units under the 2009 Performance Incentive Plan and will vest and pay out on the same schedule as the related awards.
After this grant, he directly holds 461,521 shares of common stock, which includes 278,415 stock units that will settle one-for-one in common shares. He also has indirect holdings of 784 shares through his IRA and 207 shares through his spouse's IRA.
Sabra Health Care REIT, Inc.February 27, 2026 as a grant or award. The units were credited as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and carry no purchase price.
These stock units will vest and be paid in shares of common stock on the same schedule as the original awards, on a one-for-one basis. Following this acquisition, Matros directly holds 928,398 common shares, and indirectly holds 1,857,686 shares through the R&A Matros Revocable Trust.